ustekinumab
janssen
['ibd', 'crohn', 'ustekinumab']
#berndbokemeyer real-world evidence on comparative effectiveness of ustekinumab vs anti-tnf in cd with propensity score adjustment: two-year maintenance phase results from the prospective observational run-cd study. #ecco2023 #ibd 
Professor of Medicine, Gastroenterologist, specializing in the care of patients with IBD.
National representative of Germany @ https://t.co/Qr0PthTmU8 ex @Y_ECCO_IBD chair